SOLVAC SA-REG (SOLV.BR) Fundamental Analysis & Valuation

EBR:SOLV • BE0003545531

Current stock price

64.4 EUR
-1 (-1.53%)
Last:

This SOLV.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. SOLV.BR Profitability Analysis

1.1 Basic Checks

  • SOLV had positive earnings in the past year.
  • Of the past 5 years SOLV 4 years were profitable.
  • The reported operating cash flow has been mixed in the past 5 years: SOLV reported negative operating cash flow in multiple years.
SOLV.BR Yearly Net Income VS EBIT VS OCF VS FCFSOLV.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

  • SOLV has a Return On Assets of 4.55%. This is in the better half of the industry: SOLV outperforms 62.32% of its industry peers.
  • With a Return On Equity value of 5.00%, SOLV perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
  • With a Return On Invested Capital value of 3.65%, SOLV perfoms like the industry average, outperforming 49.28% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for SOLV is below the industry average of 7.32%.
  • The last Return On Invested Capital (3.65%) for SOLV is above the 3 year average (3.44%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.55%
ROE 5%
ROIC 3.65%
ROA(3y)4.3%
ROA(5y)2.1%
ROE(3y)4.67%
ROE(5y)2.26%
ROIC(3y)3.44%
ROIC(5y)N/A
SOLV.BR Yearly ROA, ROE, ROICSOLV.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • The Profit Margin of SOLV (95.09%) is better than 98.55% of its industry peers.
  • SOLV's Profit Margin has improved in the last couple of years.
  • SOLV's Operating Margin of 97.93% is amongst the best of the industry. SOLV outperforms 100.00% of its industry peers.
  • In the last couple of years the Operating Margin of SOLV has grown nicely.
Industry RankSector Rank
OM 97.93%
PM (TTM) 95.09%
GM N/A
OM growth 3Y-0.21%
OM growth 5Y2.47%
PM growth 3Y-1.44%
PM growth 5Y1.71%
GM growth 3YN/A
GM growth 5YN/A
SOLV.BR Yearly Profit, Operating, Gross MarginsSOLV.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 100 200 300 400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. SOLV.BR Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, SOLV has about the same amount of shares outstanding.
  • SOLV has about the same amout of shares outstanding than it did 5 years ago.
  • SOLV has a better debt/assets ratio than last year.
SOLV.BR Yearly Shares OutstandingSOLV.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SOLV.BR Yearly Total Debt VS Total AssetsSOLV.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 4.37 indicates that SOLV is not in any danger for bankruptcy at the moment.
  • SOLV has a better Altman-Z score (4.37) than 89.86% of its industry peers.
  • A Debt/Equity ratio of 0.06 indicates that SOLV is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.06, SOLV belongs to the top of the industry, outperforming 88.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 4.37
ROIC/WACCN/A
WACCN/A
SOLV.BR Yearly LT Debt VS Equity VS FCFSOLV.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • SOLV has a Current Ratio of 0.69. This is a bad value and indicates that SOLV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.69, SOLV is doing worse than 91.30% of the companies in the same industry.
  • SOLV has a Quick Ratio of 0.69. This is a bad value and indicates that SOLV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SOLV has a Quick ratio of 0.69. This is amonst the worse of the industry: SOLV underperforms 84.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.69
SOLV.BR Yearly Current Assets VS Current LiabilitesSOLV.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. SOLV.BR Growth Analysis

3.1 Past

  • SOLV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.57%.
  • SOLV shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 26.70% yearly.
  • The Revenue for SOLV has decreased by -38.28% in the past year. This is quite bad
  • The Revenue has been growing by 24.62% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-38.57%
EPS 3Y-29.04%
EPS 5Y26.7%
EPS Q2Q%28%
Revenue 1Y (TTM)-38.28%
Revenue growth 3Y-28%
Revenue growth 5Y24.62%
Sales Q2Q%26.75%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y6.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SOLV.BR Yearly Revenue VS EstimatesSOLV.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B
SOLV.BR Yearly EPS VS EstimatesSOLV.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 5 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. SOLV.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.93 indicates a reasonable valuation of SOLV.
  • Based on the Price/Earnings ratio, SOLV is valued cheaper than 89.86% of the companies in the same industry.
  • SOLV's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.50.
  • SOLV is valuated cheaply with a Price/Forward Earnings ratio of 4.43.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SOLV indicates a rather cheap valuation: SOLV is cheaper than 100.00% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of SOLV to the average of the S&P500 Index (22.67), we can say SOLV is valued rather cheaply.
Industry RankSector Rank
PE 10.93
Fwd PE 4.43
SOLV.BR Price Earnings VS Forward Price EarningsSOLV.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SOLV.BR Per share dataSOLV.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.64
PEG (5Y)0.41
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. SOLV.BR Dividend Analysis

5.1 Amount

  • SOLV has a Yearly Dividend Yield of 6.24%, which is a nice return.
  • The stock price of SOLV dropped by -21.46% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • SOLV's Dividend Yield is rather good when compared to the industry average which is at 2.46. SOLV pays more dividend than 91.30% of the companies in the same industry.
  • SOLV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 6.24%

5.2 History

  • The dividend of SOLV has a limited annual growth rate of 1.34%.
Dividend Growth(5Y)1.34%
Div Incr Years0
Div Non Decr Years0
SOLV.BR Yearly Dividends per shareSOLV.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

  • The dividend of SOLV is growing, but earnings are growing more, so the dividend growth is sustainable.
DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
SOLV.BR Yearly Income VS Free CF VS DividendSOLV.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

More info and screens

Find the best dividend stocksShow peers with best dividend

SOLV.BR Fundamentals: All Metrics, Ratios and Statistics

SOLVAC SA-REG

EBR:SOLV (3/24/2026, 7:00:00 PM)

64.4

-1 (-1.53%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-06
Earnings (Next)07-30
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.24%
Ins Owner ChangeN/A
Market Cap1.38B
Revenue(TTM)132.44M
Net Income(TTM)125.93M
Analysts44
Price Target108.27 (68.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.24%
Yearly Dividend5.8
Dividend Growth(5Y)1.34%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10.93
Fwd PE 4.43
P/S 10.4
P/FCF N/A
P/OCF N/A
P/B 0.55
P/tB 0.55
EV/EBITDA N/A
EPS(TTM)5.89
EY9.15%
EPS(NY)14.52
Fwd EY22.55%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.19
BVpS117.7
TBVpS117.7
PEG (NY)1.64
PEG (5Y)0.41
Graham Number124.89
Profitability
Industry RankSector Rank
ROA 4.55%
ROE 5%
ROCE 4.86%
ROIC 3.65%
ROICexc 3.74%
ROICexgc 3.74%
OM 97.93%
PM (TTM) 95.09%
GM N/A
FCFM N/A
ROA(3y)4.3%
ROA(5y)2.1%
ROE(3y)4.67%
ROE(5y)2.26%
ROIC(3y)3.44%
ROIC(5y)N/A
ROICexc(3y)3.44%
ROICexc(5y)N/A
ROICexgc(3y)3.61%
ROICexgc(5y)N/A
ROCE(3y)4.58%
ROCE(5y)N/A
ROICexgc growth 3Y-27.07%
ROICexgc growth 5Y31.12%
ROICexc growth 3Y-24.14%
ROICexc growth 5Y34%
OM growth 3Y-0.21%
OM growth 5Y2.47%
PM growth 3Y-1.44%
PM growth 5Y1.71%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.69
Altman-Z 4.37
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.57%
EPS 3Y-29.04%
EPS 5Y26.7%
EPS Q2Q%28%
EPS Next Y6.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-38.28%
Revenue growth 3Y-28%
Revenue growth 5Y24.62%
Sales Q2Q%26.75%
Revenue Next Year3.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.25%
EBIT growth 3Y-28.15%
EBIT growth 5Y27.7%
EBIT Next Year44.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y35.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.44%
OCF growth 3YN/A
OCF growth 5YN/A

SOLVAC SA-REG / SOLV.BR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SOLVAC SA-REG?

ChartMill assigns a fundamental rating of 4 / 10 to SOLV.BR.


What is the valuation status of SOLVAC SA-REG (SOLV.BR) stock?

ChartMill assigns a valuation rating of 5 / 10 to SOLVAC SA-REG (SOLV.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for SOLVAC SA-REG?

SOLVAC SA-REG (SOLV.BR) has a profitability rating of 5 / 10.


How financially healthy is SOLVAC SA-REG?

The financial health rating of SOLVAC SA-REG (SOLV.BR) is 4 / 10.